Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Jul-24 6:00 PM View:  | Kymera Therapeutics, Inc. (KYMR) | 16-Jul-24 | Option Exercise | 23,145 | $2.08 | $48,141.60 | 24% 95.47K to 118.61K | |
| 16-Jul-24 6:00 PM View: | Kymera Therapeutics, Inc. (KYMR) | 16-Jul-24 | Planned Option Sale | 23,145 | $45.81 | $1,060,220.00 | (20%) 118.61K to 95.47K | |
| 16-Jul-24 6:00 PM View: | Kymera Therapeutics, Inc. (KYMR) | 15-Jul-24 | Option Exercise | 16,455 | $2.08 | $34,226.40 | 17% 95.74K to 112.19K | |
| 16-Jul-24 6:00 PM View: | Kymera Therapeutics, Inc. (KYMR) | 15-Jul-24 | Planned Option Sale | 16,455 | $45.15 | $742,925.00 | (15%) 112.19K to 95.74K | |
| 04-Mar-24 6:21 PM View: | Kymera Therapeutics, Inc. (KYMR) | 04-Mar-24 | Sale | 3,344 | $41.86 | $139,967.00 | (3%) 99.08K to 95.74K | |
| 04-Mar-24 6:21 PM View: | Kymera Therapeutics, Inc. (KYMR) | 01-Mar-24 | Grant | 24,375 | -- | -- | 33% 74.71K to 99.08K | |
| 29-Feb-24 10:00 PM View: | Kymera Therapeutics, Inc. (KYMR) | 27-Feb-24 | Option Exercise | 400 | $2.08 | $832.00 | < 1% 74.71K to 75.11K | |
| 29-Feb-24 10:00 PM View: | Kymera Therapeutics, Inc. (KYMR) | 27-Feb-24 | Planned Option Sale | 400 | $45.00 | $18,000.00 | (< 1%) 75.11K to 74.71K | |
| 09-Feb-24 7:47 PM View: | Kymera Therapeutics, Inc. (KYMR) | 09-Feb-24 | Option Exercise | 46,137 | $2.08 | $95,965.00 | 62% 74.71K to 120.85K | |
| 09-Feb-24 7:47 PM View: | Kymera Therapeutics, Inc. (KYMR) | 09-Feb-24 | Planned Option Sale | 46,137 | $35.50 | $1,638,070.00 | (38%) 120.85K to 74.71K | |
| 03-Mar-23 10:00 PM View: | Kymera Therapeutics, Inc. (KYMR) | 02-Mar-23 | Sale (Planned) | 1,298 | $31.00 | $40,233.30 | (2%) 76.01K to 74.71K | |
| 03-Mar-23 10:00 PM View: | Kymera Therapeutics, Inc. (KYMR) | 01-Mar-23 | Grant | 18,750 | -- | -- | 33% 57.26K to 76.01K | |
| 04-May-22 9:02 AM View: | Kymera Therapeutics, Inc. (KYMR) | 04-May-22 | Option Exercise | 20,000 | $1.69 | $33,739.80 | 54% 37.26K to 57.26K | |
| 03-Mar-22 10:00 PM View: | Kymera Therapeutics, Inc. (KYMR) | 01-Mar-22 | Grant | 12,600 | -- | -- | 51% 24.66K to 37.26K | |
| 02-Nov-21 6:45 PM View: | Kymera Therapeutics, Inc. (KYMR) | 02-Nov-21 | Option Exercise | 14,996 | $2.08 | $31,191.70 | 61% 24.66K to 39.65K | |
| 02-Nov-21 6:45 PM View: | Kymera Therapeutics, Inc. (KYMR) | 02-Nov-21 | Market Sale (Planned) | 14,996 | $63.22 | $948,063.00 | (38%) 39.65K to 24.66K | |
| 02-Nov-21 6:45 PM View: | Kymera Therapeutics, Inc. (KYMR) | 01-Nov-21 | Option Exercise | 24,607 | $1.45 | $35,782.60 | 58% 42.55K to 67.15K | |
| 02-Nov-21 6:45 PM View: | Kymera Therapeutics, Inc. (KYMR) | 01-Nov-21 | Market Option Sale (Planned) | 39,603 | $61.78 | $2,446,800.00 | (59%) 67.15K to 27.55K | |
| 02-Nov-21 6:45 PM View: | Kymera Therapeutics, Inc. (KYMR) | 01-Nov-21 | Market Sale (Planned) | 2,894 | $61.78 | $178,800.00 | (11%) 27.55K to 24.66K | |
| 15-Mar-21 9:12 PM View: | Kymera Therapeutics, Inc. (KYMR) | 15-Mar-21 | Option Exercise | 7,800 | $1.31 | $10,218.00 | 17% 45.05K to 52.85K | |
| 15-Mar-21 9:12 PM View: | Kymera Therapeutics, Inc. (KYMR) | 15-Mar-21 | Market Option Sale (Planned) | 5,305 | $60.17 | $319,202.00 | (10%) 52.85K to 47.55K | |
| 15-Mar-21 9:12 PM View: | Kymera Therapeutics, Inc. (KYMR) | 15-Mar-21 | Market Sale (Planned) | 5,000 | $60.17 | $300,850.00 | (11%) 47.55K to 42.55K | |
| 15-Mar-21 9:12 PM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Mar-21 | Option Exercise | 2,200 | $1.31 | $2,882.00 | 5% 47.55K to 49.75K | |
| 15-Mar-21 9:12 PM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Mar-21 | Market Option Sale (Planned) | 4,695 | $60.05 | $281,939.00 | (9%) 49.75K to 45.05K | |
| 24-Feb-21 6:44 PM View: | Kymera Therapeutics, Inc. (KYMR) | 24-Feb-21 | Market Sale (Planned) | 8,675 | $50.91 | $441,671.00 | (15%) 56.22K to 47.55K | < 1% |
| 24-Feb-21 6:44 PM View: | Kymera Therapeutics, Inc. (KYMR) | 23-Feb-21 | Market Sale (Planned) | 19,285 | $49.65 | $957,554.00 | (26%) 75.51K to 56.22K | (2%) |
| 24-Feb-21 6:44 PM View: | Kymera Therapeutics, Inc. (KYMR) | 22-Feb-21 | Market Sale (Planned) | 9,104 | $52.63 | $479,130.00 | (11%) 84.61K to 75.51K | 4% |
| 19-Feb-21 7:27 PM View: | Kymera Therapeutics, Inc. (KYMR) | 19-Feb-21 | Market Sale (Planned) | 8,887 | $55.09 | $489,559.00 | (10%) 93.5K to 84.61K | (1%) |
| 19-Feb-21 7:27 PM View: | Kymera Therapeutics, Inc. (KYMR) | 18-Feb-21 | Market Sale (Planned) | 6,499 | $55.94 | $363,540.00 | (6%) 100.0K to 93.5K | < 1% |
| 19-Feb-21 7:27 PM View: | Kymera Therapeutics, Inc. (KYMR) | 17-Feb-21 | Market Sale (Planned) | 7,550 | $58.39 | $440,836.00 | (7%) 107.55K to 100.0K | 5% |